New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence

Chinese Academy of Medical Sciences & Peking Union Medical College

Status: Enrolling

Conditions: Ovarian Cancer

Treatments: Other: No intervention in clinical treatment

Study type: Observational

Funder types: Other

Identifiers

NCT05410028

PUMCH-OC2

Details and patient eligibility

About

In this study, mass spectrometry was used to analyze immune inflammation-related protein complexes, post-translational modified glycopeptide omics and tumor-related metabolomics in serum, respectively, in order to find potential metabolic small molecule biomarkers or marker profiles that can be used for early diagnosis of cancer recurrence.

Full description

Time cohort study: patients with confirmed ovarian epithelial cancer at different time cutoff points before treatment, after surgery, during chemotherapy, and after chemotherapy, until clinically confirmed patients relapse. At least 50 patients are expected to be enrolled.

Enrollment: 1,000 estimated patients

Sex: Female

Ages: 20 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Female
• A diagnosed patient with epithelial ovarian cancer
• Age ≤ 70

Exclusion criteria

• Male
• Suffering from other malignant tumors
• Non-compliant patient
• Age above 70